Strategic Decision Making in the Life Sciences Industry: Managing the Build vs. Buy Dilemma

Webcast


REGISTER

1.0 CPE Credit

In the field of Specialized Knowledge (SK)

Delivery: This webcast will be delivered via the BDO Online CPE Network

Prerequisites: None

Advanced Prep: None

Program Level: Basic

Learning Objectives:

  • Describe how to evaluate the alignment of CDMOs with their strategic objectives, including considerations for speeding up time-to-market, accessing specialized technologies, and navigating regulatory landscapes.
  • Discuss the costs and benefits of partnering with CDMOs versus investing in in-house capabilities, considering both direct and indirect costs.
  • Review how outsourcing to CDMOs can help mitigate various risks, including those related to quality control, regulatory compliance, and supply chain vulnerabilities.
  • Explore how other life sciences companies have navigated their build vs. buy decisions with CDMOs, including the challenges faced and the outcomes achieved.

BDO USA, P.C., is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org

Brad Stewart

Principal, National Life Sciences Leader

BDO USA

James Neal

Principal, EBA NetSuite Practice Leader

BDO USA

Contact

Stacey Lesanto

Emailmail

Technical Support

+1 844-580-6963

BDO Employees

+1 844-580-6963

Share

Webcast


REGISTER

Contact

Stacey Lesanto

Emailmail

Technical Support

+1 844-580-6963

BDO Employees

+1 844-580-6963

Share

Related Events & Webcasts

Webcast

Creative Capital Strategies for Life Sciences Companies: Maximizing Funding Opportunities Throughout the Development Process

In the rapidly evolving landscape of the life sciences sector, securing funding is a critical step for the success and growth of companies.

Register

Webcast

Non-Dilutive Funding & Valuable Resources: Strategies for Growth Without Giving Up Equity

Join our professionals as they delve into the intricacies of non-dilutive funding, covering a range of opportunities from grants to government contracts and beyond.

Register

Webcast

Navigating the IPO Landscape in Life Sciences: Strategies for Success Amid Market Volatility

This insightful webcast, designed specifically for professionals in the life sciences sector, aims to equip you with the knowledge and strategies to navigate the IPO process in a less favorable economic climate.

Register

Webcast

Fortifying Cybersecurity in Life Sciences: A Comprehensive Approach

In an era where digital transformation is not just an advantage but a necessity, life sciences companies are increasingly becoming targets for cyber threats and data breaches.

Register

Recording

Harnessing Opportunities within Innovative Project Delivery

This webcast delves into the transformative potential of Public-Private Partnerships (P3s) under the Infrastructure Investment and Jobs Act (IIJA). Discover how strategic alignment with IIJA provisions can open new avenues for funding and enhance the execution of complex infrastructure projects through innovative delivery methods.

View Recording

Recording

Taking Stock of Private Equity Mid-2023

Join BDO’s Private Equity Leaders for a discussion on where private equity sits midway through the year, informed by takeaways from our latest survey of more than 400 fund managers and operating partners and 250 portfolio company CFOs and board members.

View Recording

Recording

Privacy and Website Compliance - Cookies, Consent, Tracking, Oh My!

Join the final webcast of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

View Recording

Recording

Interpretation of BARDA’s Priorities for 2023: Preparedness for the Next Pandemic Threat

This webinar will provide a review of the highlights from BARDA Industry Day 2022, presentation of new initiatives to support pandemic preparedness, and recommendations of best practices for potential partners to be well positioned to respond to new opportunities.

View Recording

Recording

Health Apps and HIPAA Business Associates’ Rising Obligations in Privacy and Health Data

Join our second webcast of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

View Recording

Recording

HIPAA Privacy and Security: Recent Trends in Regulation, Enforcement, and Risk Management

Join this first webinar of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

View Recording

Recording

The Evolving Federal Funding Landscape and Business Implications for the Life Sciences Industry

As Federal Government Agencies tasked with biodefense and public health continue response efforts to the acute phase of the COVID-19 pandemic, each Agency continues to balance strategic legacy initiatives and new fiscal year priorities.

View Recording

Recording

What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks

With over 200 SPAC and IPO’s over the last year, SPACs are hotter than ever. US stocks continue to be unpredictable, finding the right opening to debut on Wall Street can be tricky and costly. But are SPAC’s the right approach for most Life Sciences companies seeking capital.

View Recording

Recording

Federal Government Funding Opportunities for the Life Sciences Industry

The federal government has prioritized R&D for Covid-19 response efforts and will continue to do so until the health threat has been addressed. As these countermeasures are developed and deployed, the federal government’s biodefense R&D resources will be re-prioritized to address chemical, biological, radiological and nuclear threats, influenza and other emerging infectious diseases.

View Recording

Recording

Life Sciences and the Technical/GxP Virtual Audit – The Show Must Go On

In the face of COVID-19, the mission becomes even more critical. Innovation such as finding a way to continue to work without interruption due to CDC protocols, such as social distancing and travel bans, is imperative. Thanks to leveraging technology, we have made it possible to perform audits from a remote location, a method known as the “virtual audit”.

View Recording

Recording

2020 BDO Biotech Briefing

BDO’s annual Biotech Briefing examines the most recent 10-K SEC filings of companies listed on the NASDAQ Biotechnology Index. Join us as we analyze this year's findings and trends in the marketplace

View Recording

Recording

Planning for a Return to Work: Considerations and Implications for the Life Sciences Industry

As the COVID-19 pandemic progresses, many executives are starting to rationalize how their teams safely return to work. With restrictions varying between regions and countries, it can be difficult to develop a comprehensive strategy. This challenge is further compounded by economic uncertainty and supplier dependencies.

View Recording

See All Events & Webcastschevron_right